Biohoo Life Science Directory
|
|
4SC
4SC AG develops new drug candidates for pharmaceuticals industry. By using its proprietary, innovative technology platform, the company is able to reduce the time and cost of the drug discovery process, while at the same time increasing success rates. |
Germany
|
|
|
Actar AB
Actar was founded in year 2000. The majority owner is Karolinska Development II. The Company is a biomedical company who builds the bridge from academic research that futher pharmaceutical development needs by identifying, selecting and refining innovative biological targets. |
|
Sweden
|
|
|
Actelion
Actelion aims to discover or in-license and develop a steady stream of new products as revenue sources, based on first-in class small molecule compounds. In doing so, Actelion is focussing on innovative treatments for high-unmet medical needs, where Actelion's new drugs can bring therapeutic advantage to patients and economic benefit for the community at large. |
|
Switzerland
|
|
|
Alligator Bioscience AB
Alligator Bioscience uses its proprietary FIND (Fragment INduced Diversity) technology to develop new and optimize existing therapeutic and diagnostic proteins. Founded in 2001 in Lund, Sweden, Alligator Bioscience has a highly qualified staff where approximately half hold a Ph.D. The team has extensive experience from industry and academia as well as profound competence in key fields such as molecular biology, immunology, diagnostics, virology, enzymology, and cell biology. |
|
Sweden
|
|
|
Amura Limited
Amura is a focused and highly productive structure-based drug design company involved in discovering and developing new medicines for unmet and emerging healthcare needs. Amura is operating from modern purpose built premises providing more than 8500 square feet of laboratory and office space at Comberton on the outskirts of Cambridge. |
|
England
|
<<
Start <
Prev 1 2 3 4 5 6 7 8 9 10 Next >
End >>
